Brain Protein Shields Against Alzheimer's Damage in Mice

A protein already present in your brain might be one of the best defenses against Alzheimer's disease, and scientists just figured out how it works.

Researchers at Sanford Burnham Prebys discovered that a protein called SORLA can protect the brain from toxic tau tangles, the twisted clumps that damage memory and thinking in Alzheimer's patients. The findings, published in Science Advances on July 17, 2026, could open the door to new treatments that boost this natural shield.

For years, scientists knew that SORLA could help prevent amyloid plaques, one hallmark of Alzheimer's. But nobody understood if it could also fight tau tangles, the other major culprit in brain damage.

"Very little was known about whether SORLA affected the tau tangles reflected on the other side of the coin in Alzheimer's disease," said Timothy Huang, assistant professor at Sanford Burnham Prebys. His team decided to find out.

They bred mice that produced extra human SORLA with mice that develop tau tangles and memory problems. The results were striking: mice with more SORLA had less brain shrinkage, healthier connections between brain cells, and better preserved memory function.

The protein works by blocking tau from twisting into harmful shapes and stopping these damaged proteins from recruiting others into larger toxic clumps. It also protected synapses, the vital communication points between neurons that allow memories to form and stick.

To test the opposite scenario, researchers studied mice that couldn't make any SORLA at all. These animals experienced much worse brain damage, confirming that the protein plays a crucial protective role.

Why This Inspires

The discovery matters because it reveals how our brains naturally defend themselves against disease. Some people carry genetic mutations that reduce their SORLA production, which may explain why they face higher Alzheimer's risk.

Even better, the research uncovered a specific receptor that becomes overactive when SORLA levels drop. Drugs already exist that can target this receptor, meaning scientists might be able to repurpose existing medications to treat tau-related dementia.

"There are unique drugs that can target this class of receptors that we may be able to apply to tau-related dementia disorders," said Huang. The team plans to test these drugs and study how different brain cell types respond when SORLA levels change.

While this research is still in mice, it represents a major step toward understanding how we might strengthen the brain's natural defenses. For the millions of families touched by Alzheimer's, that's a genuinely hopeful direction.